A new study by Indiana University researchers, published in the journal BMC Public Health, explored people’s beliefs about overdose and naloxone as a step to understanding why some communities are not using the reversal medication.
A five-year study has highlighted the importance of healthy sleep patterns in relation to future binge-drinking and cannabis use in adolescence and young adulthood, as reported in Alcoholism: Clinical and Experimental Research. The work builds on growing evidence that sleep characteristics are predictive of future substance use and related problems in young people, and could inform strategies for substance use prevention and intervention. Most previous studies assessed only a small range of sleep characteristics, and had limited follow-up. In the new analysis, researchers used six annual assessments from the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) study to examine whether multiple sleep characteristics in any year predict alcohol and cannabis use the following year. Data from over eight hundred NCANDA study participants, aged 12 to 21 at baseline, were included.
University Hospitals (UH) Connor Whole Health and Susan Samueli Integrative Health Institute (SSIHI) at University of California, Irvine have joined in collaboration to lead BraveNet -- the first and largest whole health, practice-based research network in the U.S.
Deaths involving alcohol use disorder increased dramatically during the pandemic, according to a new study by Cedars-Sinai investigators. The study also found that young adults 25 to 44 years old experienced the steepest upward trend in alcohol use disorder mortality.
A new study by Indiana University researchers explored people’s beliefs about overdose and naloxone as a step to understanding why some communities are not using the reversal medication.
People addicted and dependent on opioids who used buprenorphine not prescribed by a physician at the time they enter a treatment center are more likely to remain in treatment for opioid use disorder, according to a Rutgers study.
New research finds people who were using buprenorphine obtained without a prescription were more likely to remain in treatment for opioid-use disorder, underscoring need to expand access to this medication.
Treating pregnant women with opioid use disorder can help minimize opioid-related brain abnormalities in their newborns. Led by scientists at Cedars-Sinai, this is the first study to report evidence validating the benefits of using medication for opioid use disorder during pregnancy.
In a new paper published in JAMA, researchers evaluated mental health and substance use among homeless and housed high school students surveyed voluntarily and anonymously in 2019.
Study finds that patients of orthopaedic and urologic procedures were more likely to dispose of their extra opioid tablets when they received kits in the mail to do so
Through a collaboration, a virtual “bridge clinic” will expand access to more extensive and personalized care for patients struggling with opioid use
New research from the University of California, Irvine, finds that drug withdrawal-induced anxiety and reinstatement of drug seeking behaviors are controlled by a single pathway in the brain and centered around dopamine cells.
Substantial differences exist between the texts of the posts from Twitter users who self-report nonmedical prescription drug use (NMPDU) and those who do not, and between males and females who report NMPDU, according to a recent study from Emory University.
Despite the ability of any Michigan pharmacy to dispense medication to combat opioid overdose without writing prescriptions, slightly more than half of pharmacies in the state offer the drug in such a way.
Researchers at Wake Forest University School of Medicine have been awarded a five-year, $4 million grant through the National Institutes of Health (NIH) Helping End Addiction Long-term (HEAL) Initiative to study chronic pain and opioid use disorder.
he COVID-19 pandemic has spiked the overdose death rate from opioid use. For people who rely on medications (buprenorphine, methadone, and extended-release naltrexone) to treat opioid use disorders, the pandemic and such natural disasters as tornados, hurricanes, and wildfires can disrupt access to medications.
Frank Williams was raised in the church playing the keyboard, but by the age of 13, he was introduced to illegal substances and began selling marijuana by his freshman year of high school. A decade later, Williams was selling heroin and slowly became addicted to the substance through what he called a “shake habit” — which is when the substance seeps into your pores from touching it so much.
University of Kentucky experts on the front lines of the nation’s opioid and addiction crises will share their work in the field of opioid use disorder research, treatment and prevention this week at the 2022 Rx Drug Abuse & Heroin Summit in Atlanta April 18-22.
The rate of overdose deaths among U.S. teenagers nearly doubled in 2020, the first year of the COVID pandemic, and rose another 20% in the first half of 2021 compared with the 10 years before the pandemic, even as drug use remained generally stable during the same period.
There is good news for people suffering from depression, anxiety, substance abuse, and other mental health disorders. New research published in the journal Clinical Psychological Science explains how people who have suffered from mental illness can go on to develop a long-lasting sense of well-being and achieve a “high-functioning” life.
Gunshot survivors experience serious increases in mental health disorders, substance use disorders, and pain in the year following a firearm injury Survivors’ family members also experience a rise in mental health disorders such as depression, anxiety, and PTSD in the year after loved ones’ injuries
Findings from a new animal study suggest that cannabidiol (CBD) and tetrahydrocannabinol (THC) might be safe for use with opioid pain relievers. Although more studies are needed, the results suggest that these compounds might be a low-risk way to reduce the dose of opioids needed to relieve pain.
While it's estimated that 1 in 3 Americans will develop a substance use disorder in their lifetime, experts know little about the long-term outcomes for people with substance use disorder symptoms from adolescence through adulthood.
Dr. Barbara Waszczak, Professor of Pharmacology at Northeastern University's Bouvé College of Health Sciences, is the Principal Investigator and Project Director for the grant.
A study of a nationally representative database of 105,988 admissions referred to treatment by the criminal justice system who reported heroin or other opiate as their primary, secondary, or tertiary substance used showed that fewer than 6 percent of cases received opioid agonist treatment as part of the treatment plan. Those with daily substance use, comorbid psychiatric problems, prior treatment, females, Latinos, and those who were older and those who were living independently were more likely to receive this treatment, as were those living in the Northeast and with government health insurance.
A study in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), published by Elsevier, reports that, among youth with substance use and depression, a significant proportion show early improvements in depression during their treatment for substance use.
A study in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), published by Elsevier, reports that, among youth with substance use and depression, a significant proportion show early improvements in depression during their treatment for substance use.
Receiving psychosocial and behavioral therapy alongside medications for opioid use disorder leads to better treatment engagement and continuity, according to Rutgers researchers.
Despite strong evidence that medication is the most effective treatment for opioid use disorder (OUD), adolescents and most adults who might benefit from OUD treatment report no medication use, according to a study by researchers at the Rutgers School of Public Health and Columbia University Mailman School of Public Health.
The Foundation for Opioid Response Efforts, a private 501(c)(3) national grant-making foundation focused on ending the nation’s opioid crisis, today announced nine new grants totaling $10.9 million over three years to fund prevention programs for vulnerable children and families across the country.
Providing patients with chronic back pain and osteoarthritis (OA) access to medical cannabis can reduce or even eliminate the use of opioids for pain management, according to two studies presented at the 2022 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
_RGB Blue20230706101098.jpg&width=400&height=400)
Medications for opioid-use disorder (OUD) are associated with lower death rates and improved quality of life for people in recovery.
Pain experts and patient advocates had expressed concern that these laws may restrict access to opioid treatment for people with chronic pain without substituting effective non-opioid alternatives.
Irvine, Calif., March 11, 2022 — A new University of California, Irvine-led study establishes important conceptual connections between the fields of circadian rhythms, metabolism, and addiction. Going beyond current studies on substance use disorders, which focus on the impact of addictive drugs on the brain, this new research highlights an existing connection between specific neurons and peripheral organs.
With overdoses at a record high, there's an urgent need to expand the capacity for primary care providers to treat people with opioid use disorder. Programs in Alabama and North Carolina have developed effective models for training primary care providers to provide life-saving treatment for OUD. Read about it in an Issue Brief from the Foundation for Opioid Response Efforts (FORE).
A new study finds that school-based health center providers lack the training and confidence to successfully deliver opioid misuse interventions.
Rutgers researchers examined how often youth who overdosed on a benzodiazepine or stimulant had a recent medical prescription for that drug.
Don't miss these articles in our Staff Picks channel
Results from a new clinical trial demonstrate that an eight-week mindfulness-based therapy—Mindfulness-Oriented Recovery Enhancement (MORE)—decreased opioid use and misuse while reducing chronic pain symptoms, with effects lasting as long as nine months.
In 2020, the first year of the COVID-19 pandemic, the rate of drug overdose deaths among Black Americans surpassed that of whites for the first time since 1999 — a sharp reversal of the situation a decade earlier, when rates were twice as high for whites as for Blacks.
New research from scientists at Cummings School of Veterinary Medicine at Tufts University supports and builds on the researchers’ previous findings that opioid use in female rats before pregnancy—even if not used during pregnancy itself—could result in a higher likelihood that male offspring will develop type 2 diabetes and metabolic syndrome, conditions that increase the risk of heart disease and stroke.
A Rutgers expert discusses the rise of fentanyl deaths nationwide—and how they can be averted
During periods of extreme heat, clinicians should expect to see an increase in patients requiring mental health services, according to a new study led by Boston University School of Public Health researchers.
People with alcohol use disorder (AUD) have a distorted perception of the richness of imagined future scenarios, according to a study in Alcoholism: Clinical and Experimental Research. The findings could have important implications for AUD treatment and rehabilitation. The ability to imagine specific future events is a type of mental time travel known as episodic future thinking (EFT). EFT contributes to a range of skills needed to safely navigate daily life, including planning, goal-directed behavior, and emotional regulation. Previous research has indicated that people with short-sighted maladaptive behaviors, such as drug misuse and excessive gambling, tend to imagine future events that lack vividness and specificity. Impaired EFT was also suspected to be of clinical importance in AUD, but little was known about the mechanisms underlying the impairment.
The Icahn School of Medicine at Mount Sinai has been awarded a three-year, $2.1 million Health Workforce Resiliency grant from the Health Resources & Services Administration (HRSA) to develop a new training initiative that will promote well-being, enhance resilience, and aim to reduce the burden of mental health conditions, substance abuse, and suicidal ideation among the health professional workforce.
By: Kathleen Haughney | Published: February 16, 2022 | 8:51 am | SHARE: With 15-year-old Russian figure skater Kamila Valieva under the world’s microscope for her alleged use of a banned substance, the outcomes of the team competition and potentially the women’s competition may be in doubt.Florida State University’s renowned experts are available to discuss the use of banned substances in athletic competitions with the news media.
PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic. They’re expanding the library of known fentanyl analogs and predicting new forms that might exist someday.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
